NCT02555735View on ClinicalTrials.gov

Exceptional Responders With Solid Tumor Cancer to Chemotherapy

Enrolling by invitationOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2026

Study Completion Date

August 31, 2027

Conditions

Solid Tumor Neoplasms

Interventions

DRUG

Standard of Care Chemotherapy

Physician's Choice Chemotherapy Treatment (non-guided)

Trial Locations (1)

90024

The Pancreatic Cancer Treatment Center of Los Angeles, Los Angeles

Sponsors

Lead Sponsor

Adera Labs, LLC

All Listed Sponsors

collaborator

The Pancreatic Cancer Treatment Center of Los Angeles

UNKNOWN

lead

Adera Labs, LLC

INDUSTRY